PMID: 6201492Apr 1, 1984Paper

Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes

The Journal of Cell Biology
R A WeissT T Sun

Abstract

The polypeptide composition of epidermal keratin varies in disease. To better understand the biological meaning of these variations, we have analyzed keratins from a number of human epidermal diseases by the immunoblot technique using AE1 and AE3 monoclonal antikeratin antibodies. The results reveal a continuous spectrum of keratin expression ranging from one closely resembling the normal in vivo pattern to one almost identical to cultured epidermal keratinocytes. Specifically, a 50-kilodalton (kd) (AE1-positive) and a 58-kd (AE3-positive) keratin are present in all diseases, supporting the concept that they represent "permanent" markers for keratinocytes. A 56.5-kd (AE1) and a 65-67-kd (AE3) keratin, previously shown to be markers for keratinization, are expressed only by lesions retaining a keratinized morphology. A 48-kd (AE1) and a 56-kd (AE3) keratin are present in all hyperproliferative (para- or nonkeratinized) disorders, but not in normal abdominal epidermis or in ichthyosis vulgaris which is a nonhyperproliferative disease. These two keratins have previously been found in various nonepidermal keratinocytes undergoing hyperproliferation, suggesting that these keratins are not epidermis-specific and may represent markers...Continue Reading

References

Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·T T SunH Green
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·W W FrankeK Weber
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Apr 1, 1979·The British Journal of Dermatology·M Levine, A McLeod
Jun 19, 1979·Biochimica Et Biophysica Acta·J KubilusH P Baden
Dec 11, 1979·Biochemistry·P M Steinert, W W Idler
Dec 20, 1978·Biochimica Et Biophysica Acta·D Skerrow, I Hunter
Sep 1, 1980·Archives of Dermatology·M J LeVineH P Baden
Apr 17, 1981·Biochimica Et Biophysica Acta·I Hunter, D Skerrow
Jan 1, 1981·Archives of Dermatological Research·M J StaquetJ Thivolet
Jan 1, 1982·Archives of Dermatology·H P BadenA Fletcher
Nov 1, 1982·The Journal of Cell Biology·J Woodcock-MitchellT T Sun
Feb 28, 1983·Biochimica Et Biophysica Acta·P E BowdenW J Cunliffe
Apr 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S J FeyJ E Celis
Jan 1, 1983·Differentiation; Research in Biological Diversity·R MollW W Franke
Jan 12, 1982·Biochimica Et Biophysica Acta·L Hunter, D Skerrow
Oct 1, 1980·Archives of Dermatology·R M Adrian, H P Baden

❮ Previous
Next ❯

Citations

Jan 30, 1999·The Journal of Pathology·M P AndriessenJ Schalkwijk
Aug 1, 1996·Journal of Cellular Physiology·F Van RuissenJ Schalkwijk
Sep 1, 1996·Journal of Cellular Physiology·F van RuissenJ Schalkwijk
Jan 1, 1995·Teratogenesis, Carcinogenesis, and Mutagenesis·M BlessingB L Hogan
Jan 1, 1991·Archives of Dermatological Research·M ThewesD Mischke
Jan 1, 1993·Archives of Dermatological Research·K YoshikawaS Kondo
Jan 1, 1992·Archives of Dermatological Research·J Fransson, H Hammar
Jan 1, 1992·Archives of Dermatological Research·W JungkunzH Holzmann
Jan 1, 1991·Archives of Dermatological Research·I Moll, R Moll
Jan 1, 1986·Archives of Dermatological Research·Y Katagata, K Aso
Jan 1, 1987·Archives of Dermatological Research·F M WattN E Fusenig
Jan 1, 1989·Archives of Oto-rhino-laryngology·W Y Chao, C C Huang
Jan 1, 1989·Archives of Dermatological Research·K Ito, K Hashimoto
Jan 1, 1988·Virchows Archiv. A, Pathological Anatomy and Histopathology·D BroekaertE Gillis
Jan 1, 1992·Virchows Archiv. A, Pathological Anatomy and Histopathology·P StosiekR Moll
Oct 1, 1988·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·F GreifL B Taichman
Jun 1, 1990·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·D OdaG Bourekis
May 8, 2008·Histochemistry and Cell Biology·Roland MollLutz Langbein
Jun 26, 2009·Biogerontology·Véronique Bertrand-ValleryFlorence Debacq-Chainiaux
Oct 1, 1988·Trends in Genetics : TIG·E Fuchs
Mar 1, 1995·Clinics in Dermatology·I A McKay, I M Leigh
Jul 1, 1996·Clinics in Dermatology·K M Albers
Jul 1, 1990·Journal of Dermatological Science·M YaarB A Gilchrest
Jul 1, 1994·Journal of Dermatological Science·J A RothnagelD R Roop
Apr 27, 2004·Experimental Eye Research·Robert M LavkerTung-Tien Sun
Oct 1, 1986·Journal of the American Academy of Dermatology·R Eichner
Jan 24, 1998·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·I Spies
Apr 29, 1998·General Pharmacology·R Gniadecki
Aug 11, 1998·Journal of Dermatological Science·M Tomic-CanicM Blumenberg
Mar 1, 1995·Nature Genetics·W H McLeanC Higgins
Jan 20, 1999·The British Journal of Dermatology·O SwenssonR A Eady
May 22, 2001·Veterinary Dermatology·J H Walter
Aug 11, 1998·Differentiation; Research in Biological Diversity·T MagnaldoM Darmon

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.